New chikungunya vaccine trial aims to shield thousands
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine called BBV87 to see if it can protect healthy people aged 12 to 65 from chikungunya, a virus spread by mosquitoes that causes fever and joint pain. About 1,000 volunteers will receive the vaccine and be monitored for side effects and immune response…
Phase: PHASE2, PHASE3 • Sponsor: Bharat Biotech International Limited • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:40 UTC